301 related articles for article (PubMed ID: 24658400)
1. Genetic deletion of the mitochondrial phosphate carrier desensitizes the mitochondrial permeability transition pore and causes cardiomyopathy.
Kwong JQ; Davis J; Baines CP; Sargent MA; Karch J; Wang X; Huang T; Molkentin JD
Cell Death Differ; 2014 Aug; 21(8):1209-17. PubMed ID: 24658400
[TBL] [Abstract][Full Text] [Related]
2. The mitochondrial ATP synthase is a negative regulator of the mitochondrial permeability transition pore.
Pekson R; Liang FG; Axelrod JL; Lee J; Qin D; Wittig AJH; Paulino VM; Zheng M; Peixoto PM; Kitsis RN
Proc Natl Acad Sci U S A; 2023 Dec; 120(51):e2303713120. PubMed ID: 38091291
[TBL] [Abstract][Full Text] [Related]
3. A modified calcium retention capacity assay clarifies the roles of extra- and intracellular calcium pools in mitochondrial permeability transition pore opening.
Harisseh R; Abrial M; Chiari P; Al-Mawla R; Villedieu C; Tessier N; Bidaux G; Ovize M; Gharib A
J Biol Chem; 2019 Oct; 294(42):15282-15292. PubMed ID: 31434742
[TBL] [Abstract][Full Text] [Related]
4. What is the mitochondrial permeability transition pore?
Halestrap AP
J Mol Cell Cardiol; 2009 Jun; 46(6):821-31. PubMed ID: 19265700
[TBL] [Abstract][Full Text] [Related]
5. Genetic manipulation of the cardiac mitochondrial phosphate carrier does not affect permeability transition.
Gutiérrez-Aguilar M; Douglas DL; Gibson AK; Domeier TL; Molkentin JD; Baines CP
J Mol Cell Cardiol; 2014 Jul; 72():316-25. PubMed ID: 24768964
[TBL] [Abstract][Full Text] [Related]
6. The mitochondrial permeability transition: a current perspective on its identity and role in ischaemia/reperfusion injury.
Halestrap AP; Richardson AP
J Mol Cell Cardiol; 2015 Jan; 78():129-41. PubMed ID: 25179911
[TBL] [Abstract][Full Text] [Related]
7. Genetic ablation of calcium-independent phospholipase A(2)γ (iPLA(2)γ) attenuates calcium-induced opening of the mitochondrial permeability transition pore and resultant cytochrome c release.
Moon SH; Jenkins CM; Kiebish MA; Sims HF; Mancuso DJ; Gross RW
J Biol Chem; 2012 Aug; 287(35):29837-50. PubMed ID: 22778252
[TBL] [Abstract][Full Text] [Related]
8. Opening of mitochondrial permeability transition pore induces hypercontracture in Ca2+ overloaded cardiac myocytes.
Ruiz-Meana M; Abellán A; Miró-Casas E; Garcia-Dorado D
Basic Res Cardiol; 2007 Nov; 102(6):542-52. PubMed ID: 17891523
[TBL] [Abstract][Full Text] [Related]
9. Slow calcium waves and redox changes precede mitochondrial permeability transition pore opening in the intact heart during hypoxia and reoxygenation.
Davidson SM; Yellon DM; Murphy MP; Duchen MR
Cardiovasc Res; 2012 Mar; 93(3):445-53. PubMed ID: 22198507
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Bcl-2 sensitizes mitochondrial permeability transition pore (MPTP) opening in ischemia-damaged mitochondria.
Chen Q; Xu H; Xu A; Ross T; Bowler E; Hu Y; Lesnefsky EJ
PLoS One; 2015; 10(3):e0118834. PubMed ID: 25756500
[TBL] [Abstract][Full Text] [Related]
11. Interplay between Ca2+ cycling and mitochondrial permeability transition pores promotes reperfusion-induced injury of cardiac myocytes.
Abdallah Y; Kasseckert SA; Iraqi W; Said M; Shahzad T; Erdogan A; Neuhof C; Gündüz D; Schlüter KD; Tillmanns H; Piper HM; Reusch HP; Ladilov Y
J Cell Mol Med; 2011 Nov; 15(11):2478-85. PubMed ID: 21199327
[TBL] [Abstract][Full Text] [Related]
12. Distinct mPTP activation mechanisms in ischaemia-reperfusion: contributions of Ca2+, ROS, pH, and inorganic polyphosphate.
Seidlmayer LK; Juettner VV; Kettlewell S; Pavlov EV; Blatter LA; Dedkova EN
Cardiovasc Res; 2015 May; 106(2):237-48. PubMed ID: 25742913
[TBL] [Abstract][Full Text] [Related]
13. circEZH2 inhibits opening of mitochondrial permeability transition pore via interacting with PiC and up-regulating RSAD2.
Guo J; Liu Z; Zhang D; Lai Y; Gao J; Wang X; Lin J; Zhang X; Zhang F; Zhao X; Tong D
Vet Microbiol; 2022 Sep; 272():109497. PubMed ID: 35785658
[TBL] [Abstract][Full Text] [Related]
14. Opening of mitochondrial permeability transition pore in cardiomyocytes: Is ferutinin a suitable tool for its assessment?
Bréhat J; Panel M; Ghaleh B; Morin D
Fundam Clin Pharmacol; 2023 Aug; 37(4):739-752. PubMed ID: 36797226
[TBL] [Abstract][Full Text] [Related]
15. Heart failure-induced activation of phospholipase iPLA
Moon SH; Liu X; Cedars AM; Yang K; Kiebish MA; Joseph SM; Kelley J; Jenkins CM; Gross RW
J Biol Chem; 2018 Jan; 293(1):115-129. PubMed ID: 29158256
[TBL] [Abstract][Full Text] [Related]
16. The roles of phosphate and the phosphate carrier in the mitochondrial permeability transition pore.
Varanyuwatana P; Halestrap AP
Mitochondrion; 2012 Jan; 12(1):120-5. PubMed ID: 21586347
[TBL] [Abstract][Full Text] [Related]
17. CaMKII determines mitochondrial stress responses in heart.
Joiner ML; Koval OM; Li J; He BJ; Allamargot C; Gao Z; Luczak ED; Hall DD; Fink BD; Chen B; Yang J; Moore SA; Scholz TD; Strack S; Mohler PJ; Sivitz WI; Song LS; Anderson ME
Nature; 2012 Nov; 491(7423):269-73. PubMed ID: 23051746
[TBL] [Abstract][Full Text] [Related]
18. ROS-mediated PARP activity undermines mitochondrial function after permeability transition pore opening during myocardial ischemia-reperfusion.
Schriewer JM; Peek CB; Bass J; Schumacker PT
J Am Heart Assoc; 2013 Apr; 2(2):e000159. PubMed ID: 23598272
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial permeability transition pore-dependent necrosis.
Robichaux DJ; Harata M; Murphy E; Karch J
J Mol Cell Cardiol; 2023 Jan; 174():47-55. PubMed ID: 36410526
[TBL] [Abstract][Full Text] [Related]
20. Recent progress in elucidating the molecular mechanism of the mitochondrial permeability transition pore.
Leung AW; Halestrap AP
Biochim Biophys Acta; 2008; 1777(7-8):946-52. PubMed ID: 18407825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
